VivoSim Labs VIVS
NASDAQ VIVS
$0.17 +0.01 (+8.24%)
As of: Oct 20, 2026 · 10:18 AM EDT

VivoSim Labs (VIVS) Receivables - Other (2020)

Updated

VivoSim Labs' Receivables - Other was $28,000 in fiscal Q1 2021 (quarter ended Jun 30, 2020).

Analysis

VivoSim Labs (VIVS) Receivables - Other (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.44 Bn 36.14 Bn 1.44 Bn
2 Medpace Holdings 17.76 Bn 15.83 Bn 201.64 Mn
3 Charles River Laboratories International 14.76 Bn 13.95 Bn 363.37 Mn
4 Icon 13.70 Bn 10.82 Bn 479.29 Mn
5 Fortrea Holdings 2.18 Bn 1.56 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 633.98 Mn -128.10 Mn 18.44 Mn
7 Evotec SE 518.53 Mn -1.09 Bn -
8 Champions Oncology 65.18 Mn 40.27 Mn 7.70 Mn
9 MindWalk Holdings 61.22 Mn 24.88 Mn 1.61 Mn
10 VivoSim Labs 901,187.49 -16.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 28,000.00
API Access

VivoSim Labs Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=VIVS&period=max&api_key=YOUR_API_KEY